Reuters: Astra drug tipped as $8-9 billion cholesterol winner

[chris]

Astra drug tipped as $8-9 billion cholesterol winner
      

LONDON (Reuters) - AstraZeneca Plc's  Crestor is emerging as a potential big winner in the fiercely competitive anti-cholesterol market, with two brokerages on Tuesday hiking sales forecasts for the drug to $8-9 billion.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login